| Quarterly Financials | Mar 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 216 | 278 | 260 | 293 | 331 | 402 | 300 | 296 | 300 | 303 | 334 | 328 | 342 | 282 | 314 | 293 | 326 | 384 | 318 | 338 | 319 | 407 | 432 | 421 | 545 | 438 | 487 | 516 | 547 | 596 | 533 | 600 | 809 | 599 |
| Expenses | 192 | 260 | 276 | 318 | 325 | 350 | 294 | 295 | 292 | 277 | 305 | 288 | 296 | 255 | 300 | 284 | 313 | 302 | 311 | 352 | 345 | 419 | 395 | 407 | 435 | 532 | 443 | 452 | 448 | 504 | 504 | 571 | 476 | 540 |
| EBITDA | 24 | 18 | -16 | -25 | 5 | 52 | 6 | 1 | 8 | 26 | 29 | 40 | 46 | 27 | 14 | 9 | 13 | 83 | 7 | -14 | -26 | -12 | 37 | 14 | 110 | -94 | 44 | 64 | 99 | 93 | 29 | 29 | 332 | 59 |
| Operating Profit % | -3 % | -10 % | -14 % | -22 % | -7 % | 7 % | -7 % | -10 % | -6 % | 5 % | 4 % | 9 % | 9 % | 7 % | -1 % | 2 % | -0 % | 19 % | -0 % | -7 % | -14 % | -4 % | 7 % | 2 % | 7 % | -23 % | 8 % | 11 % | 16 % | 14 % | 4 % | 1 % | 9 % | 6 % |
| Depreciation | 11 | 14 | 14 | 16 | 18 | 19 | 18 | 21 | 20 | 23 | 21 | 21 | 21 | 22 | 22 | 22 | 23 | 23 | 25 | 28 | 31 | 30 | 29 | 30 | 32 | 27 | 32 | 32 | 31 | 30 | 32 | 32 | 31 | 31 |
| Interest | 0 | 3 | 1 | 1 | 1 | 4 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 3 | 5 | 4 | 6 | 6 | 7 | 6 | 5 | 4 | 5 | 7 | 6 | 7 | 8 | 7 | 9 |
| Profit Before Tax | 13 | 2 | -31 | -43 | -14 | 29 | -14 | -22 | -13 | 0 | 7 | 18 | 24 | 3 | -9 | -16 | -11 | 58 | -21 | -47 | -61 | -47 | 2 | -22 | 73 | -126 | 8 | 27 | 62 | 58 | -9 | -11 | 293 | 19 |
| Tax | -16 | 4 | -10 | -2 | -14 | -9 | -8 | 1 | 1 | 18 | 5 | 9 | -0 | 3 | 2 | -3 | 3 | -14 | 3 | 23 | 3 | -3 | 3 | 3 | 0 | 3 | 6 | 3 | 4 | 5 | 1 | 1 | 29 | 8 |
| Net Profit | 29 | -2 | -21 | -41 | -0 | 38 | -6 | -22 | -15 | -17 | 2 | 9 | 24 | -0 | -12 | -13 | -14 | 72 | -23 | -71 | -64 | -44 | -1 | -25 | 73 | -129 | 2 | 25 | 58 | 53 | -11 | -12 | 264 | 11 |
| EPS in ₹ | 3.19 | 0.00 | -2.91 | -5.83 | -0.04 | 4.51 | -0.88 | -3.15 | -2.07 | -2.44 | 0.35 | 1.24 | 3.35 | -0.06 | -1.63 | -1.82 | -2.01 | 10.15 | -3.32 | -10.04 | -9.08 | -6.28 | -0.09 | -3.48 | 10.39 | -18.37 | 0.29 | 3.50 | 8.22 | 7.52 | -1.49 | -1.69 | 37.54 | 1.55 |
Unichem Laboratories
Unichem Laboratories
439.95
-7.65
(-1.71%)
Market Cap
3,097.50 Cr
PE Ratio
12.42
Volume
6,03,085.00
Day High - Low
447.40 - 426.70
52W High-Low
666.60 - 278.20
Key Fundamentals
Market Cap
3,097.50 Cr
EPS
35.91
PE Ratio
12.42
PB Ratio
1.16
Book Value
385.97
EBITDA
184.17
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
5.61
Debt to Equity
0.14
Actual
Company News
View All News
Unichem Laboratories Limited will hold its 63rd AGM on August 11, 2026, via video conference. The cut-off date for determining shareholder eligibility is August 4, 2026.
Unichem Q4 Net Profit at ₹10.91 Crore
May 22, 2026
May 22, 2026Unichem Laboratories reported a consolidated net profit of ₹10.91 crore for Q4 FY26. Annual revenue rose to ₹2,201.85 crore. The board re-appointed the Managing Director for three years.
Unichem Labs Board Meet Set for May 22, 2026May 06, 2026
May 06, 2026Unichem Laboratories schedules a Board of Directors meeting on May 22, 2026, to consider Q4 and full-year FY26 financial results (standalone and consolidated).
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,806.00 | #1 4,33,319.90 | 37.67 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 50.53 | |
6,608.50 | 1,75,434.91 | 68.57 | 10,560.00 | 8.73 | 2,520 | 13.44 | 48.68 | |
4,504.00 | 1,52,435.83 | 72.41 | 13,886.20 | 20.34 | 2,138 | -26.91 | 56.10 | |
1,381.30 | 1,11,578.74 | 29.05 | 29,044.60 | 2.24 | 3,870 | -55.32 | 52.20 | |
1,088.10 | 1,09,488.32 | 21.69 | 26,719.70 | 13.65 | 5,242 | 7.82 | 63.58 | |
1,279.50 | 1,06,792.57 | 25.58 | 33,593.30 | -0.44 | 3,998 | -86.05 | 47.29 | |
2,273.10 | 1,03,890.49 | #1 19.57 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 49.08 | |
2,380.30 | 98,259.99 | 50.70 | 14,277.60 | 12.03 | 1,750 | 31.75 | 51.82 | |
1,408.30 | 81,794.29 | 24.41 | 33,384.70 | 3.21 | 3,376 | 1.99 | 40.75 | |
1,389.10 | 74,991.48 | 84.59 | 6,867.80 | #1 22.01 | 890 | 21.18 | 60.94 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
2.59 %
Net Income Growth
109.72 %
Cash Flow Change
-150.14 %
ROE
-245.71 %
ROCE
-376.83 %
EBITDA Margin (Avg.)
-46.60 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 1,169 | 1,284 | 1,527 | 3,194 | 3,150 | 3,145 | 3,126 | 3,319 | 3,193 | 3,275 | 3,569 | 3,737 |
| Fixed Assets | 416 | 403 | 491 | 578 | 810 | 870 | 884 | 990 | 1,257 | 1,252 | 1,300 | 1,311 |
| Current Assets | 564 | 600 | 749 | 2,337 | 2,038 | 1,687 | 1,377 | 1,648 | 1,589 | 1,743 | 2,030 | 2,197 |
| Capital Work in Progress | 123 | 237 | 250 | 238 | 92 | 331 | 568 | 494 | 148 | 123 | 31 | 100 |
| Investments | 35 | 14 | 14 | 901 | 926 | 550 | 392 | 264 | 2 | 1 | 0 | 975 |
| Other Assets | 595 | 630 | 772 | 1,476 | 1,321 | 1,395 | 1,282 | 1,571 | 1,787 | 1,899 | 2,239 | 3 |
| Total Equity & Liabilities | 1,169 | 1,284 | 1,527 | 3,194 | 3,150 | 3,145 | 3,126 | 3,319 | 3,193 | 3,275 | 3,569 | 3,737 |
| Current Liabilities | 212 | 243 | 393 | 464 | 503 | 567 | 506 | 552 | 640 | 738 | 992 | 886 |
| Non Current Liabilities | 89 | 86 | 70 | 50 | 27 | 47 | 63 | 148 | 118 | 99 | 127 | 134 |
| Total Equity | 868 | 954 | 1,064 | 2,680 | 2,620 | 2,531 | 2,557 | 2,618 | 2,435 | 2,438 | 2,451 | 2,717 |
| Reserve & Surplus | 849 | 936 | 1,045 | 2,666 | 2,606 | 2,517 | 2,543 | 2,604 | 2,421 | 2,424 | 2,437 | 2,703 |
| Share Capital | 18 | 18 | 18 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -25 | -7 | -1 | 655 | -616 | -78 | -154 | 32 | 75 | -29 | -65 |
| Investing Activities | -52 | -85 | -128 | 1,648 | -286 | -36 | -66 | 100 | 241 | 63 | -242 |
| Operating Activities | 78 | 112 | 68 | -112 | -328 | 20 | 33 | -260 | -85 | 14 | -7 |
| Financing Activities | -51 | -33 | 59 | -881 | -2 | -62 | -121 | 191 | -81 | -106 | 184 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 70.21 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.83 % | 0.00 % | 0.90 % | 0.89 % | 0.94 % | 1.06 % | 0.98 % | 0.98 % | 1.00 % | 0.99 % | 1.00 % |
| DIIs | 8.49 % | 8.49 % | 8.49 % | 8.49 % | 8.49 % | 8.38 % | 7.55 % | 8.20 % | 8.16 % | 7.39 % | 10.32 % | 9.29 % | 11.27 % | 11.58 % | 11.67 % | 11.63 % | 11.32 % | 10.92 % | 10.75 % | 10.74 % | 10.63 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 30.48 % | 30.39 % | 30.50 % | 30.27 % | 29.81 % | 29.95 % | 30.17 % | 30.99 % | 30.91 % | 26.86 % | 15.80 % | 15.63 % | 15.12 % | 14.80 % | 14.58 % | 14.47 % | 14.80 % | 15.16 % | 15.26 % | 15.18 % | 15.22 % |
| Others | 10.09 % | 10.19 % | 10.08 % | 10.31 % | 10.77 % | 10.73 % | 11.34 % | 9.87 % | 9.99 % | 14.81 % | 2.84 % | 4.85 % | 2.49 % | 2.50 % | 2.60 % | 2.62 % | 2.67 % | 2.72 % | 2.77 % | 2.86 % | 2.93 % |
| No of Share Holders | 0 | 33,734 | 34,258 | 33,892 | 35,313 | 33,557 | 32,666 | 29,573 | 29,418 | 26,642 | 21,584 | 20,877 | 21,171 | 20,621 | 20,374 | 21,472 | 21,621 | 23,010 | 23,577 | 23,267 | 23,386 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 3 | 5 | 4 | 4 | 4 | 4 | 4 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 1.05 | 2.57 | 2.57 | 1.29 | 1.54 | 1.39 | 0.81 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 11 Aug 2026 |  Annual General Meeting | NA | 11 Aug 2026 | 378.05 | 447.60 |
| 26 Jul 2021 |  Dividend | ₹ 4.00 /share | 22 Jul 2021 | 360.90 | 334.65 |
| 03 Aug 2022 | Dividend | ₹ 4.00 /share | 01 Aug 2022 | 232.65 | 295.00 |
| 08 Aug 2024 | Annual General Meeting | NA | 08 Aug 2024 | 537.10 | 582.45 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 802.45 | 877.05 |
| 06 Feb 2025 | Quarterly Result Announcement | NA | 06 Feb 2025 | 676.25 | 723.80 |
| 22 May 2025 | Quarterly Result Announcement | NA | 22 May 2025 | 567.75 | 609.20 |
| 04 Aug 2025 | Annual General Meeting | NA | 04 Aug 2025 | 570.15 | 608.45 |
| 04 Aug 2025 | Quarterly Result Announcement | NA | 04 Aug 2025 | 605.90 | 608.45 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 470.65 | 461.35 |
| 05 Feb 2026 | Quarterly Result Announcement | NA | 05 Feb 2026 | 424.35 | 417.65 |
| 22 May 2026 | Quarterly Result Announcement | NA | 22 May 2026 | 376.60 | 369.25 |
Announcements
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 20113 days ago
3 days agoDisclosures under Reg. 29(2) of SEBI (SAST) Regulations 20113 days ago
3 days agoAnnouncement Under Regulation 30 Of The SEBI (LODR) Regulations 2015 - Clarification On Significant Increase In The Volume Of Security.4 days ago
4 days agoClarification sought from Unichem Laboratories Ltd4 days ago
4 days agoAnnual General Meeting (AGM) Of The Company Will Be Held On Tuesday 11Th August 2026.5 days ago
5 days agoIntimation Of Transfer Of Equity Shares To Investor Education And Protection Fund (IEPF) Authority.Jun 01, 2026
Jun 01, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 01, 2026
Jun 01, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2026
May 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2026
May 23, 2026ResultsMay 22, 2026
May 22, 2026Board Meeting Outcome for Outcome Of Board MeetingMay 22, 2026
May 22, 2026Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended March 31 2026 And Audited Financial Results (Standalone And Consolidated) For The Year Ended March 31 2026.May 06, 2026
May 06, 2026Announcement Under Reg. 30 - Product RecallApr 12, 2026
Apr 12, 2026Announcement under Regulation 30 (LODR)-Credit RatingApr 10, 2026
Apr 10, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 30, 2026
Mar 30, 2026Closure of Trading WindowMar 24, 2026
Mar 24, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateMar 20, 2026
Mar 20, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 26, 2026
Feb 26, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 25, 2026
Feb 25, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015Feb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Change in ManagementFeb 05, 2026
Feb 05, 2026Financial ResultsFeb 05, 2026
Feb 05, 2026Board Meeting Outcome for Outcome Of The Board MeetingFeb 05, 2026
Feb 05, 2026Announce Under Regulation 30 (LODR) - USFDA Inspected The CompanyS Kolhapur API FacilityFeb 02, 2026
Feb 02, 2026Announcement Under Reg. 30 Of Listing RegulationsJan 27, 2026
Jan 27, 2026Final Report On Re-Lodgement Of Transfer Requests Of Physical Shares From 1St December 2025 Upto 6Th January 2026Jan 27, 2026
Jan 27, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Jan 13, 2026Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025.Jan 09, 2026
Jan 09, 2026Closure of Trading WindowDec 22, 2025
Dec 22, 20255Th Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 30Th November 2025.Dec 16, 2025
Dec 16, 20254Th Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 31St October 2025.Nov 17, 2025
Nov 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 12, 2025
Nov 12, 2025Financial Results For Quarter And Half Year Ended 30Th September 2025Nov 11, 2025
Nov 11, 2025Board Meeting Outcome for Outcome Of Board MeetingNov 11, 2025
Nov 11, 2025General UpdateOct 28, 2025
Oct 28, 2025Board Meeting Intimation for Unaudited Financial Results (Consolidated And Standalone) For The Second Quarter And Six Months Ended September 30 2025.Oct 15, 2025
Oct 15, 20253Rd Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 30Th September 2025.Oct 11, 2025
Oct 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Intimation Of Change In Email Address Of MUFG Intime India Private Limited Registrar And Share Transfer Agent (MUFG)Oct 06, 2025
Oct 06, 2025Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Oct 03, 2025
Oct 03, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025UpdateSep 18, 2025
Sep 18, 2025Report On Re-Lodgement Of Transfer Requests Of Physical Shares For The Month Ended 31St August 2025.Sep 12, 2025
Sep 12, 2025UpdateSep 03, 2025
Sep 03, 2025Unichem Laboratories Limited Received The Establishment
Inspection Report (EIR) From The United States Food And Drug
Administration (USFDA)Aug 26, 2025
Aug 26, 2025Re-Lodgement Of Transfer Requests Of Physical SharesAug 26, 2025
Aug 26, 2025Submission Of Advertisement Published In Newspapers Regarding Notice To Shareholder (100 DAYS CAMPAIGN - SAKSHAM NIVESHAK) For KYC And Other Related Updation And Unclaimed Dividend Due For Transfer To The Investor Education And Protection Fund (IEPF) AccoAug 25, 2025
Aug 25, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 05, 2025
Aug 05, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Motilal Oswal BSE 1000 Index Fund Direct-Growth | 0.00% | 1 | 0.00% | 0.00% | |
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.05% | 0 | 0.00% | -0.01% | |
 DSP Healthcare Fund Direct-Growth | 0.90% | 0 | 0.00% | -0.16% | |
 HDFC Small Cap Fund Direct-Growth | 0.49% | 0 | 0.00% | -0.07% | |
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 Quant Value Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 70.32
ATR(14)
Less Volatile 25.34
STOCH(9,6)
Neutral 67.94
STOCH RSI(14)
Overbought 94.40
MACD(12,26)
Bullish 9.96
ADX(14)
Strong Trend 25.04
UO(9)
Bearish 50.14
ROC(12)
Uptrend And Accelerating 25.66
WillR(14)
Neutral -38.74
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
